chapter
focu
manuscript
publish
past
year
focu
design
properti
recombin
attenu
bacteri
vaccin
rabv
deliveri
antigen
dna
vaccin
vector
vaccin
deliveri
system
develop
administr
mucos
surfac
prevent
infect
bacteri
viral
parasit
pathogen
caus
diseas
invad
mucos
surfac
therefor
includ
refer
use
vector
system
confer
protect
insectborn
pathogen
case
use
mucos
rout
immun
measur
mucos
antibodi
cellular
immun
respons
reader
refer
chapter
previou
edit
book
curtiss
well
recent
review
cheminay
hensel
van
huynegem
et
al
galen
et
al
hegazi
hensel
simon
et
al
baheyeldin
gahan
berlec
et
al
et
al
mohamadzadeh
well
discuss
prior
work
addit
perspect
inform
review
also
address
mean
vaccin
induc
mucos
well
system
cellular
immun
base
mucos
rout
immun
anjuer
et
al
kim
et
al
kong
et
al
regard
salmonella
vector
vaccin
critic
need
peyer
patch
pp
induc
mucos
immun
respons
product
secretori
iga
siga
oral
immun
hashizum
et
al
whether
pp
need
induc
mucos
siga
respons
recombin
attenu
salmonella
vaccin
rasv
administ
via
mucos
rout
parenter
immun
far
examin
howev
seo
et
al
use
eye
drop
immun
rasv
induc
mucos
antibodi
assay
vagin
secret
also
induc
protect
challeng
wildtyp
virul
salmonella
enterica
serovar
typhimurium
strain
previou
work
hopkin
et
al
demonstr
deliveri
rasv
strain
divers
mucos
rout
induc
antibodi
distal
mucos
site
well
serum
except
rectal
immun
result
mucos
respons
intestin
tract
contrast
kantel
et
al
observ
rectal
immun
human
volunt
antityphoid
vaccin
strain
induc
better
mucos
immun
respons
nasal
rectal
secret
tear
oral
administr
induc
better
mucos
respons
saliva
vagin
secret
rout
equival
induc
mucos
respons
intestin
secret
serum
studi
srinivasan
et
al
confirm
hopkin
result
mice
find
antibodi
respons
secret
serum
follow
oral
intranas
intravagin
immun
also
observ
true
intraperiton
immun
may
uniqu
attribut
rasv
sinc
salmonella
vaccin
colon
gutassoci
lymphoid
tissu
galt
mice
follow
intraperiton
immun
also
possibl
true
invas
vaccin
vector
potenti
colon
divers
intern
effector
lymphoid
tissu
parenter
inocul
appar
studi
compar
mice
human
rout
immun
need
evid
increas
number
studi
use
noninvas
lactic
acid
bacteria
antigen
deliveri
vector
invas
necessari
induc
mucos
respons
regard
would
valuabl
compar
studi
differ
bacteri
vector
system
use
protect
antigen
strain
mice
immunolog
evalu
includ
challeng
pathogen
strain
would
particularli
import
studi
evalu
durat
immun
protect
induct
memori
respons
wide
studi
bacteri
genera
deliveri
recombin
protect
antigen
dna
vaccin
vector
salmonella
invas
vector
lactobacillu
noninvas
vector
edwardsiella
listeria
mycobacterium
shigella
yersinia
invas
bacteria
use
clostridium
escherichia
coli
vibrio
use
noninvas
vaccin
vector
review
literatur
rabv
one
must
rememb
parent
isol
use
variou
studi
attenu
deriv
one
strain
induc
protect
strain
reciproc
necessarili
zhang
et
al
word
differ
strain
speci
also
differ
degre
abl
induc
protect
immun
also
choic
outbr
versu
specif
inbr
strain
mice
antigen
studi
significantli
impact
result
induct
immun
respons
protect
immun
sbrogioalmeida
et
al
simon
et
al
object
mucos
deliv
vaccin
induc
mucos
antibodi
cellular
immun
respons
portal
entri
bacteri
viral
fungal
parasit
pathogen
although
immun
via
rout
induc
mucos
respons
mucos
site
often
much
better
respons
least
shortterm
respons
mucos
site
use
primari
immun
unfortun
impact
rout
immun
durat
respons
memori
adequ
studi
although
oral
rout
immun
often
use
invas
salmonella
vector
vaccin
especi
enterica
serotyp
typhimurium
hereaft
typhimurium
mice
anim
increas
number
studi
often
evalu
human
adapt
enterica
serotyp
typhi
paratyphi
hereaft
typhi
paratyphi
mice
use
intranas
immun
see
pickett
et
al
galen
et
al
increas
number
studi
use
lactobacillusvector
vaccin
rout
almost
becom
norm
fulli
subscrib
investig
vaccin
way
readili
assess
work
work
best
must
remind
reader
investig
administ
vaccin
unlik
ever
approv
human
use
unless
mean
preclud
access
bacteria
product
administ
rout
brain
discov
implement
problem
clearli
demonstr
wildtyp
typhimurium
typhi
well
attenu
deriv
inocul
travers
along
olfactori
nerv
cribriform
plate
ethmoid
bone
olfactori
bulb
brain
bollen
et
al
elimin
inv
gene
block
brain
access
regard
vaccin
administ
taken
market
well
known
typhi
infect
children
result
mening
henderson
even
oral
infect
mice
wildtyp
strain
result
neurolog
symptom
associ
brain
colon
wickham
et
al
therefor
might
worth
complet
investig
use
sublingu
rout
immun
cuburu
et
al
issu
particularli
relev
use
live
invas
bacteri
strain
vaccin
vector
problem
might
also
encount
use
noninvas
bacteri
vector
particularli
true
preponder
recent
studi
lactic
acid
bacteri
vector
observ
much
better
efficaci
use
immun
compar
oral
deliveri
import
featur
highli
immunogen
live
bacteri
vaccin
vector
recruit
innat
immun
respons
usual
accompani
inflammatori
respons
howev
much
good
thing
alway
accept
thu
use
invas
bacteri
vector
possibl
lead
much
inflamm
use
typhimurium
mice
may
never
realiz
sinc
mice
get
gastroenter
typhimurium
infect
thu
safeti
evalu
degre
excess
inflammatori
respons
associ
invas
rabv
probabl
evalu
use
rabbit
ileal
loop
assay
calv
bollen
et
al
use
rabbit
ileal
loop
found
inclus
sopb
andor
msbb
mutat
typhimurium
decreas
excess
fluid
secret
inflammatori
respons
recent
kong
et
al
genet
modifi
typhimurium
synthes
mostli
monophosphoryl
lipid
nontox
adjuv
form
lipid
show
strain
excess
inflammatori
rabbit
ileal
loop
studi
vaccin
strain
modif
highli
immunogen
consider
like
import
typhi
paratyphi
vector
vaccin
human
sinc
mild
diarrhea
observ
subject
trial
tacket
et
al
much
earli
focu
develop
rasv
human
select
attenu
strategi
would
safe
efficaci
healthi
young
adult
fda
guidelin
fortun
well
codifi
germani
furer
describ
attenu
typhi
vaccin
clinic
trial
success
soon
led
test
safeti
efficaci
young
children
chile
black
et
al
earli
global
effort
identifi
major
grand
challeng
global
health
much
deliber
grand
challeng
select
first
three
develop
safe
efficaci
vaccin
newborn
vaccin
deliv
needlefre
vaccin
thermost
thu
spent
sever
year
evalu
variou
combin
attenu
mutat
render
typhimurium
total
safe
newborn
mice
retain
immunogen
one
strain
typhimurium
found
total
safe
dose
excess
cfu
newborn
mice
ld
wildtyp
parent
strain
mostli
construct
bronwyn
gunn
help
other
unabl
colon
brain
immun
bollen
et
al
immunogen
adult
li
et
al
infant
shi
et
al
malnourish
wijburg
et
al
unpublish
immunocompromis
wijburg
et
al
unpublish
mice
typhi
vaccin
strain
mutat
evalu
found
safe
human
volunt
frey
et
al
periaswami
et
al
screen
secondari
mutat
typhimurium
strain
ssav
attenu
mutat
identifi
confer
safeti
immunocompromis
mice
yet
retain
immunogen
vishwakarma
et
al
report
fur
doubl
mutant
safe
immunogen
strain
immunocompromis
mice
howev
involv
fur
upregul
hild
express
thu
enhanc
invas
function
teixido
et
al
would
suggest
inclus
fur
mutat
vaccin
strain
would
lessen
invas
thu
immunogen
peter
et
al
introduc
trxa
delet
elimin
thioredoxin
reduc
inflamm
splenomegali
iv
immun
mice
attenu
mutant
strain
still
induc
protect
salmonella
challeng
even
though
number
cell
b
lymphocyt
spleen
reduc
sinc
gene
clone
earli
recombin
dna
manipul
much
reli
plasmid
vector
antibiot
resist
marker
select
recombin
clone
cohen
et
al
follow
much
work
develop
live
recombin
bacteri
vaccin
also
use
plasmid
vector
antibioticresist
marker
select
howev
late
scientist
usda
fda
let
known
antibiot
resist
would
good
attribut
live
bacteri
vaccin
use
balancedleth
vectorhost
system
nakayama
et
al
galan
et
al
hoksok
plasmid
addict
system
galen
et
al
elimin
use
plasmid
strain
antibiot
resist
review
previous
curtiss
new
system
garmori
et
al
describ
construct
operatorrepressor
titrat
ort
system
mainten
plasmid
vector
host
strain
vivo
absenc
either
drug
resist
select
marker
system
involv
insert
laci
laci
q
sequenc
opposit
orient
p
tac
p
trc
p
lac
laco
sequenc
intact
drive
express
adjacentessenti
gene
dapd
growth
strain
depend
addit
iptg
howev
introduc
plasmidencod
protect
antigen
laco
sequenc
titrat
laci
enabl
strain
grow
absenc
iptg
loss
plasmid
caus
vaccin
cell
undergo
diaminopimel
acid
dap
less
death
lyse
garmori
et
al
report
construct
deliv
yersinia
pesti
pesti
antigen
effici
induc
complet
protect
pesti
challeng
singl
oral
immun
galen
et
al
develop
addit
novel
mean
stabl
mainten
plasmid
vector
absenc
antibiot
resist
delet
gene
encod
singlestrand
dna
bind
protein
essenti
dna
metabol
place
gene
antigenspecifi
plasmid
introduc
lethal
mutat
chromosom
vaccin
strain
requir
use
mainten
plasmid
replac
antigenspecifi
plasmid
final
rasv
construct
xin
et
al
describ
addit
balancedleth
plasmid
mainten
system
relat
requir
dalanin
peptidoglycan
synthesi
typhi
specif
restrict
human
chimp
therefor
research
direct
toward
develop
typhi
vector
vaccin
human
work
detail
use
typhimurium
construct
evalu
mice
howev
recombin
attenu
typhi
vaccin
evalu
abil
induc
mucos
system
antibodi
respons
cellular
immun
deliv
protect
antigen
use
immun
londonoarcila
et
al
morton
et
al
galen
et
al
regard
possibl
modifi
typhi
strain
infecti
mice
enabl
complet
evalu
safeti
immunogen
recombin
attenu
typhi
vaccin
spano
galan
lactic
acid
bacteria
increasingli
investig
antigen
deliveri
vector
sinc
bacteria
noninvas
unknown
caus
diseas
gener
regard
safe
gra
lactococcu
lacti
lactobacillu
casei
persist
establish
commens
oral
immun
anim
host
sinc
grow
optim
wherea
speci
grow
lactobacillu
plantarum
lactobacillu
acidophilu
lactobacillu
helveticu
lactobacillu
delbrueckii
persist
longer
immun
anim
host
potenti
establish
commens
rais
issu
induct
toler
may
also
depend
anim
host
particular
strain
lactobacillu
use
regard
possibl
induct
oral
toler
either
bacteri
vector
use
deliv
protect
antigen
importantli
deliv
protect
antigen
welldesign
studi
establish
magnitud
problem
whether
mice
human
although
mani
studi
demonstr
induct
toler
administr
purifi
antigen
without
variou
adjuv
differ
mucos
surfac
see
mestecki
et
al
need
better
understand
potenti
problem
regard
bacteri
vector
vaccin
seem
commens
bacteria
becom
toler
wherea
pathogen
may
predict
better
longterm
outcom
use
invas
bacteria
antigen
deliveri
vector
rather
deriv
commens
bacteri
strain
specul
requir
investig
kang
et
al
develop
suicid
vector
approach
gener
precis
delet
without
insert
make
use
counterselect
use
kanamycin
chloramphenicol
resist
initi
select
sucros
sensit
due
presenc
sacb
gene
select
revers
direct
creat
mutat
quickli
move
one
strain
anoth
use
transduct
hensel
describ
adapt
system
describ
datsenko
wanner
e
coli
enabl
repetit
delet
insert
often
express
cassett
typhimurium
chromosom
system
also
use
antibiot
resist
gene
transient
final
construct
antibioticsensit
one
potenti
complic
accumul
multipl
frt
scar
flp
recombinas
recognit
target
nt
place
delet
could
lead
potenti
genet
instabl
regulatori
scientist
dislik
well
antibiot
resist
live
vaccin
strain
sun
et
al
therefor
develop
strategi
analog
propos
husseini
hensel
salmonella
yersinia
gener
multipl
scarless
genet
modif
suicid
vector
coupl
transduct
method
kang
et
al
also
avoid
problem
dna
scar
kwon
et
al
also
use
fusion
uniqu
sequenc
sequenc
encod
antibiot
resist
insert
place
chromosom
delet
sequenc
use
home
nucleas
iscei
kang
et
al
recogn
uniqu
sequenc
excis
gener
scarless
allel
delet
replac
bacteri
pathogen
multipl
mean
success
pathogen
escap
recognit
innat
immun
system
suppress
modul
divert
induct
acquir
immun
success
develop
bacteri
vaccin
vector
system
therefor
depend
identifi
inactiv
mean
sopb
protein
typhimurium
effector
secret
prevent
induct
apoptosi
pyroptosi
advantag
salmonella
rather
host
knodler
et
al
delet
sopb
gene
vaccin
strain
lessen
induct
fluid
secret
intestin
tract
without
decreas
invas
also
enhanc
induct
mucos
immun
respons
jone
et
al
report
typhimurium
avra
gene
act
subvert
innat
apoptot
signal
pathway
studi
wu
et
al
reveal
howev
typhimurium
mutat
caus
extens
intestin
inflamm
led
increas
apoptosi
epitheli
cell
achiev
higher
titer
intern
organ
includ
spleen
st
john
abraham
report
typhimurium
lp
via
process
downregul
product
homeostat
chemokin
impact
function
organ
drain
lymph
node
like
modif
typhimurium
lipid
form
kong
et
al
elimin
problem
kulla
et
al
report
typhimurium
produc
lasparaginas
ii
enzym
encod
ansb
gene
enhanc
virul
inhibit
cell
respons
typhi
presum
strain
dublin
produc
vi
capsular
antigen
immunosuppress
block
invas
antiphagocyt
thu
mani
typhi
rasv
complet
partial
delet
tvi
operon
remain
seen
whether
mutat
genet
alter
lessen
induct
immun
suppress
typhimurium
mice
applic
typhi
human
hand
vi
antigen
protect
antigen
use
conjug
vaccin
prevent
typhi
infect
kossaczka
et
al
wahid
et
al
therefor
gener
effect
live
typhi
vaccin
cvd
constitut
synthes
vi
antigen
alreadi
mention
possibl
use
lactobacillu
speci
establish
commens
relationship
vaccin
host
may
induc
toler
need
investig
occur
vaccin
vector
benefit
alter
preclud
induct
toler
permit
repeat
use
vector
year
major
paper
review
live
bacteri
vaccin
note
import
ensur
complet
attenu
induct
diseas
symptom
maintain
high
immunogen
final
realiz
improb
imposs
thu
devis
number
strategi
vaccin
strain
time
administr
would
nearli
like
wildtyp
pathogen
possibl
abl
withstand
host
defens
stress
encount
colon
target
effector
lymphoid
tissu
first
strategi
design
strain
regul
delay
attenu
achiev
three
way
first
curtiss
et
al
use
salmonella
vaccin
strain
mutat
pmi
gale
deletioninsert
mutat
rfc
tt
arac
p
bad
rfc
rfah
tt
arac
p
bad
rfah
strain
would
synthes
lipopolysaccharid
lp
oantigen
andor
outer
core
suppli
sugar
mannos
galactos
andor
arabinos
growth
ceas
synthesi
vivo
sugar
would
unavail
rough
phenotyp
would
manifest
six
eight
cell
divis
vivo
curtiss
et
al
second
delet
promot
gene
essenti
virul
pathogen
replac
arac
p
bad
regulatori
cassett
express
gene
would
depend
presenc
arabinos
vaccin
strain
growth
would
ceas
express
vivo
due
absenc
arabinos
case
imposit
attenu
gradual
sinc
gene
product
dilut
half
cell
divis
vivo
third
strategi
regul
delay
lysi
vaccin
strain
vivo
system
design
releas
bolu
protect
antigen
kong
et
al
dna
vaccin
vector
kong
et
al
provid
total
biolog
contain
vaccin
persist
vivo
surviv
vaccin
strain
shed
fece
mani
problem
presenc
attenu
mutat
time
immun
due
lessen
abil
vaccin
strain
contend
host
defens
time
entranc
bodi
achiev
reason
titer
bacteri
vaccin
cell
effector
lymphoid
tissu
strategi
regul
delay
attenu
note
design
contend
problem
suspect
later
effort
improv
mean
vaccin
strain
surviv
stress
enhanc
induct
protect
immun
respons
anoth
problem
mean
attenu
reduct
abil
vaccin
strain
attach
invad
colon
lymphoid
tissu
well
known
structur
lp
much
influenc
attach
intestin
epithelium
due
reduc
abil
travers
mucin
thu
neg
impact
immunogen
kong
et
al
made
seri
defin
mutat
better
defin
problem
base
result
studi
import
wildtyp
level
lp
present
vaccin
cell
time
immun
anim
host
presenc
rpo
mutat
typhimurium
diminish
strain
abil
colon
galt
oral
immun
coynault
et
al
nickerson
curtiss
thu
decreas
immunogen
potenti
problem
deriv
typhi
also
possess
rpo
mutat
robbesaul
norel
lastli
mean
attenu
elimin
reduc
product
display
pathogen
associ
molecular
pattern
pamp
interact
tolllik
receptor
tlr
cytosol
nucleotidebind
oligomer
domain
nod
initi
innat
immun
respons
impair
like
reduc
immunogen
whether
problem
exist
often
evalu
use
cell
line
hek
cell
endow
respons
given
pamp
due
presenc
singl
tlr
nod
recogn
sinc
synthesi
protect
antigen
sometim
toxic
vaccin
cell
reduc
growth
effici
colon
effector
lymphoid
tissu
thu
select
delet
portion
gene
encod
protein
sequenc
multipl
cystein
residu
encod
hydrophob
domain
often
help
altern
strategi
use
promot
activ
vivo
p
nirb
chatfield
et
al
p
pagc
hohmann
et
al
even
help
univers
usabl
recent
develop
univers
mean
regul
delay
synthesi
vivo
recombin
protect
antigen
system
plasmidencod
antigen
gene
control
strong
promot
p
trc
growth
vaccin
strain
repress
laci
produc
respons
growth
vaccin
cultur
presenc
arabinos
due
arac
p
bad
laci
cassett
recogn
express
gene
encod
recombin
antigen
often
contribut
attenu
sinc
loss
antigen
synthesi
capabl
would
restor
virul
well
recogn
recombin
antigen
synthesi
could
reli
basi
attenu
howev
yang
et
al
report
overexpress
antigen
synthesi
basi
attenu
make
cell
permeabl
thu
suscept
host
destruct
term
attenu
gene
express
age
reason
state
would
unaccept
human
vaccin
although
might
accept
vaccin
use
agricultur
import
anim
base
report
teixido
et
al
fur
activ
express
hild
thu
gene
increas
invas
follow
overexpress
fur
time
mucos
immun
could
increas
colon
malt
observ
use
regul
delay
attenu
associ
fur
gene
express
thu
typhimurium
vaccin
strain
tt
arac
p
bad
fur
construct
invas
better
colon
pp
strain
tt
arac
p
bad
fur
construct
synthes
less
fur
grown
medium
arabinos
note
strategi
might
ideal
vaccin
strain
design
overexpress
furregul
gene
iron
acquisit
protein
due
problem
iron
toxic
addit
mean
increas
invas
report
kong
et
al
replac
hila
promot
p
trc
lack
laco
sequenc
wildtyp
strain
hila
p
hila
construct
invas
colon
lymphoid
tissu
higher
level
lower
ld
wildtyp
parent
enhanc
virul
observ
howev
vaccin
strain
attenu
mutat
although
increas
invas
tissuecolon
abil
retain
kong
et
al
particul
antigen
often
immunogen
possibl
persist
immun
although
debat
whether
capsom
form
pentam
complet
capsid
synthesi
attenu
salmonella
strain
baud
et
al
found
highli
immunogen
ameiss
et
al
made
fusion
expos
region
influenza
viru
woodchuck
hepat
core
whc
enabl
format
core
particl
within
attenu
typhimurium
vaccin
strain
compos
subunit
sequenc
splice
spike
domain
higher
titer
mucos
iga
serum
igg
respons
induc
use
typhimurium
antigen
deliveri
strain
exhibit
regul
delay
lysi
vivo
kong
et
al
strain
undergo
program
lysi
mice
immun
lyse
rasv
exhibit
protect
challeng
tcid
wsn
influenza
viru
administ
intranas
use
viru
antigen
hbv
core
form
highli
immunogen
particul
antigen
discuss
chapter
preced
edit
book
curtiss
learn
rabv
construct
interact
immun
host
becom
worthwhil
investig
coexpress
sequenc
encod
cytokin
chemokin
immun
modul
might
improv
immun
respons
induc
effort
initi
late
product
attenu
typhimurium
strain
saltzman
et
al
part
antitumor
therapi
strategi
one
interest
applic
technolog
deliveri
human
treatment
inflammatori
bowel
diseas
chromosom
insert
sequenc
encod
replac
thya
gene
l
lacti
steidler
et
al
anoth
interest
applic
design
attenu
typhimurium
synthes
swine
use
adjuv
enhanc
bias
protect
pseudorabi
viru
coadminist
prv
vaccin
studi
rabv
deliv
cytokin
list
section
chapter
although
result
report
encourag
detail
wellcontrol
studi
need
better
delin
express
cofactor
would
enhanc
immun
respons
protect
especi
regard
mucos
immun
respons
protect
pathogen
infect
via
mucos
surfac
note
howev
yoon
et
al
discov
engin
commerci
dna
vaccin
vector
specifi
synthesi
deliv
wildtyp
typhimurium
low
dose
result
attenu
salmonella
although
yoon
et
al
suggest
mean
attenu
virul
pathogen
transform
vaccin
would
argu
like
oversynthesi
recombin
antigen
safe
accept
reliabl
mean
rabv
attenu
sinc
loss
abil
synthes
would
restor
virul
although
progress
improv
rabv
deliveri
protect
antigen
dna
vaccin
impress
still
much
learn
thu
could
benefit
know
design
strain
would
target
specif
tissu
cell
type
andor
cell
compart
direct
antigen
specif
deliveri
class
andor
class
ii
present
still
fulli
understand
achiev
safe
persist
product
antigen
understand
mean
mechan
immun
host
kill
lyse
bacteri
vaccin
cell
releas
process
protect
antigen
although
much
work
focus
deliveri
protect
protein
antigen
mean
deliv
protect
carbohydr
antigen
mostli
unstudi
mean
enhanc
product
outer
membran
vesicl
omv
highli
immunogen
would
valuabl
arena
immunolog
need
understand
better
induc
longterm
memori
respons
mucos
immun
oppos
shortterm
local
mucos
immun
respons
term
safeti
efficaci
studi
focus
immun
respons
rabv
age
individu
although
plasmidspecifi
synthesi
protect
antigen
gener
norm
rabv
system
chromosom
integr
still
sometim
use
either
low
amount
protect
antigen
need
stimul
cellular
immun
antigen
high
amount
toxic
bacteri
cell
decreas
growth
rate
lessen
abil
colon
effector
lymphoid
tissu
sinc
gene
express
level
vari
greatli
depend
site
direct
chromosom
insert
one
must
empir
determin
optim
locat
proxim
origin
chromosom
replic
might
better
higher
level
antigen
synthesi
desir
also
import
select
design
modif
promot
region
increas
translat
effici
inclus
doubl
lysin
aaa
codon
immedi
start
codon
stenstrom
et
al
regard
plasmid
specifi
recombin
protect
antigen
certain
featur
discuss
preced
section
host
bacteria
thu
although
use
antibiot
resist
marker
plasmid
vector
conveni
stabil
construct
assur
vivo
regulatori
agenc
frown
upon
inclus
antibiot
resist
live
bacteri
vaccin
ultim
clinic
commerci
use
mean
regul
delay
synthesi
recombin
protect
antigen
vivo
also
discuss
mean
achiev
higher
level
rabv
colon
effector
lymphoid
tissu
level
synthesi
recombin
protect
antigen
influenc
choic
plasmid
vector
differ
copi
number
sometim
requir
modif
level
synthesi
select
marker
sinc
excess
synthesi
level
caus
hyperattenu
reduc
fit
vaccin
strain
kang
et
al
xin
et
al
thu
elimin
alter
promot
andor
shinedalgarno
sequenc
high
copi
number
plasmid
often
necessari
one
way
enhanc
level
antigen
synthesi
induc
antibodi
respons
use
runaway
plasmid
replic
vector
maintain
low
copi
number
growth
strain
vivo
releas
repress
lead
plasmid
amplif
high
level
protect
antigen
synthesi
note
system
also
provid
complet
biolog
contain
sinc
runaway
plasmid
replic
seem
revers
viabl
vaccin
cell
recov
mucos
immun
addit
balancedleth
vectorhost
system
number
investig
use
complement
delet
mutat
lethal
vivo
constrain
surviv
andor
persist
vaccin
strain
use
c
chromosom
delet
mutat
use
plasmid
vector
possess
complement
wildtyp
allel
balancedleth
system
overexpress
complement
gene
high
copi
number
vector
also
result
hyperattenu
less
efficaci
induct
protect
immun
sizemor
et
al
compar
deliveri
pesti
lcrv
antigen
typhimurium
strain
mutat
function
plasmid
copi
number
select
marker
case
pbr
ori
vector
superior
puc
ori
vector
asd
balancedleth
plasmid
addict
system
yield
higher
antibodi
titer
use
purb
glna
complement
system
describ
express
gene
encod
plasmid
vector
often
accomplish
use
promot
permit
constitut
synthesi
protect
antigen
howev
often
interfer
abil
rabv
effici
colon
effector
lymphoid
tissu
thu
reduc
immunogen
construct
make
use
either
vivoactiv
promot
regul
delay
vivo
express
gene
encod
protect
antigen
one
first
mean
investig
secret
protect
antigen
use
associ
hemolysin
secret
e
coli
see
curtiss
although
still
use
investig
inferior
mean
deliveri
protect
antigen
rabv
cell
next
system
describ
use
secret
antigen
cell
importantli
transloc
cytosol
host
cell
process
proteasom
class
present
augment
induct
ctl
respons
initi
work
use
effector
fuse
antigen
cell
epitop
see
curtiss
recent
husseini
et
al
expand
antigen
deliveri
character
use
associ
effector
antigen
deliveri
regard
effector
ssef
seem
work
best
xu
et
al
also
evalu
number
vivoactiv
promot
deliveri
model
antigen
ova
note
later
section
mani
mucos
administ
rabv
stimul
antibodi
product
mucos
site
also
cellular
immun
fact
signific
need
better
character
induc
cellular
immun
sinc
earli
work
rabv
often
result
induc
high
antibodi
titer
synthes
protect
antigen
compar
high
titer
antibodi
induc
rabv
antigen
kang
et
al
investig
use
signal
sequenc
deliv
streptococcu
pneumonia
pspa
protect
antigen
cytosol
periplasm
studi
antibodi
titer
pspa
antigen
high
antibodi
titer
salmonella
lp
outer
membran
protein
omp
found
pspa
antigen
supernat
fluid
compar
studi
use
yield
antibodi
titer
pspa
time
titer
pspa
retain
interior
rasv
strain
kang
curtiss
sinc
ctermin
sequenc
also
enhanc
secret
koshland
botstein
branger
et
al
found
inclus
ntermin
ctermin
signal
sequenc
led
better
secret
higher
antibodi
titer
pesti
lcrv
antigen
xin
et
al
investig
use
sever
signal
peptid
consensu
date
fusion
effici
export
protect
antigen
achiev
lysi
rabv
vivo
gener
made
use
block
synthesi
uniqu
peptidoglycan
constitu
due
delet
mutat
gene
synthesi
regul
synthesi
enzym
peptidoglycan
synthesi
caus
regul
delay
cessat
synthesi
peptidoglycan
either
case
cell
wallless
death
occur
releas
protect
antigen
present
rabv
cell
time
lysi
grangett
et
al
gener
alanin
racemasedefici
l
lacti
l
plantarum
strain
found
superior
induc
tetanu
antitoxin
c
antibodi
l
plantarum
strain
superior
especi
induc
antitoxin
iga
respons
intestin
secret
thu
lysi
releas
synthes
antigen
superior
mean
antigen
deliveri
especi
induc
mucos
immun
zhao
et
al
jiang
et
al
listeria
monocytogen
strain
deliv
antigen
observ
one
strain
induct
mice
protect
mucos
antibodi
cellular
respons
measur
challeng
gagencod
recombin
vaccinia
viru
vector
significantli
induct
high
number
gagspecif
cell
observ
malt
follow
oral
vaccin
kong
et
al
design
rasv
strain
regul
delay
lysi
vivo
use
arabinosedepend
arac
p
bad
regul
express
asda
mura
gene
special
design
regul
delay
lysi
plasmid
deregul
synthesi
antisens
mrna
mura
asda
gene
complet
prevent
express
chromosom
mura
gene
express
also
arac
p
bad
regul
strain
possess
mutat
block
synthesi
colan
acid
abl
protect
cell
undergo
cell
wallless
death
rela
mutat
also
ensur
complet
lysi
uncoupl
cell
growth
depend
protein
synthesi
system
use
obtain
better
immun
respons
protect
antigen
achiev
nonlysi
rasv
strain
ameiss
et
al
ashraf
et
al
juarezrodriguez
et
al
juarezrodriguez
et
al
encod
two
differ
protect
antigen
fusion
two
antigen
one
deliv
regul
delay
lysi
plasmid
antigen
would
secret
either
two
mean
continu
prior
cell
lysi
bolu
synthes
antigen
releas
discuss
lysi
gramneg
rabv
releas
lp
lipid
endotoxin
possibl
caus
excess
inflamm
even
sepsi
sever
mean
allevi
problem
modif
lipid
kong
et
al
kong
et
al
kramer
et
al
encod
autotransport
aidai
caus
diffus
adhes
e
coli
intestin
epitheli
cell
thya
plasmid
vector
mainten
attenu
thya
typhimurium
vaccin
strain
fusion
sever
antigen
aidai
result
surfac
local
confirm
rizo
et
al
use
heliocobact
pylori
urea
epitop
fuse
surfac
display
present
breau
et
al
encod
autotransport
hgba
ptetcnirb
vector
use
typhimurium
vaccin
strain
enabl
surfac
antigen
display
isoda
et
al
made
ctermin
fusion
porphyomona
gingivali
hemagglutinin
hagb
lppompa
fusion
display
surfac
attenu
typhimurium
synthesi
fusion
protein
toxic
necessit
modif
p
trc
lead
decreas
antigen
synthesi
construct
induc
much
higher
serum
antibodi
igg
iga
higher
vagin
iga
isogen
vaccin
strain
retain
hagb
cytoplasm
work
group
pathangey
et
al
demonstr
level
protect
antigen
synthes
alter
fit
rasv
strain
higher
level
synthesi
correl
less
fit
result
rapid
induct
especi
mucos
immun
respons
kim
et
al
construct
vector
use
l
lacti
enabl
fusion
domain
surfac
proteas
target
fusion
protein
cell
surfac
vector
surfac
local
protect
antigen
l
lacti
raha
et
al
l
casei
hou
et
al
l
acidophilu
chu
et
al
moeini
et
al
kajikawa
et
al
l
plantarum
del
rio
et
al
describ
case
comparison
made
surfac
display
antigen
led
higher
antibodi
titer
deliv
antigen
antigen
synthes
retain
cytoplasm
although
much
evid
secret
surfac
display
protect
antigen
rabv
strain
yield
better
immun
respons
protect
immun
kang
curtiss
see
alway
true
sizemor
et
al
found
much
higher
antibodi
titer
pesti
lcrv
antigen
induc
retain
cytoplasm
attenu
typhimurium
strain
rather
secret
inclus
multipl
plasmid
encod
multipl
protect
antigen
complex
plasmid
encod
multipl
antigen
operon
juarezrodriguez
et
al
multipl
gene
independ
regul
often
result
genet
instabl
due
interand
intraplasmid
recombin
typhimurium
activ
encod
recf
recj
gene
delet
enhanc
plasmid
stabil
gene
enzym
encod
even
present
salmonella
serotyp
reca
mutat
also
includ
result
total
attenu
pathogen
potenti
reduc
immunogen
contrast
recf
recj
mutat
alter
virul
colon
abil
typhimurium
mani
studi
conduct
past
year
explor
mean
construct
deliv
variou
rabv
strain
often
stimul
three
branch
immun
system
mucos
system
cellular
focu
induc
protect
immun
pathogen
colon
pass
mucos
surfac
result
diseas
much
progress
develop
new
system
appear
mani
vaccin
reach
market
place
also
rapid
expans
number
journal
publish
find
field
mucos
administ
vaccin
review
recent
literatur
found
mani
defici
would
recommend
public
mani
paper
without
addit
specif
inform
probabl
conduct
addit
experi
includ
control
add
cautionari
word
note
refer
citat
publish
work
serv
endors
accuraci
although
mani
new
system
describ
offer
promis
result
issu
safeti
efficaci
often
address
adequ
regard
induct
mucos
immun
respons
excit
observ
pertain
induct
cellular
immun
respons
mucos
tissu
rais
major
question
yet
address
meaning
way
name
durat
product
mucos
antibodi
respons
follow
immun
well
durat
induc
cellular
immun
specif
memori
respons
induc
immunolog
base
memori
regard
turnov
replac
mucos
tissu
much
rapid
intern
tissu
tabl
includ
list
recent
describ
rabv
list
infecti
diseas
address
protect
antigen
deliv
vector
system
use
refer
tabl
also
subdivid
list
invas
bacteri
vector
noninvas
bacteri
vector
salmonellabas
vaccin
continu
predomin
signific
increas
investig
noninvas
commens
noncommens
lactic
acid
bacteri
vector
substanti
present
discuss
key
find
follow
mu
et
al
evalu
mani
ironregul
promot
e
tarda
found
p
dp
p
ynce
gave
highest
transcript
sequenc
encod
protect
antigen
dehydrogenas
gapdh
fish
pathogen
aeromona
hydrophlia
plasmid
vector
antibioticresist
marker
introduc
variou
attenu
e
tarda
strain
recombin
use
bath
vaccin
turbot
scophtalmu
maximu
protect
immun
intramuscular
im
challeng
e
tarda
hydrophilia
observ
mucos
immun
evalu
santand
et
al
choi
kim
develop
balancedleth
recombin
vector
system
antigen
deliveri
e
ictaluri
e
tarda
respect
delet
asda
gene
aspart
semialdehyd
dehydrogenas
impos
oblig
requir
dap
case
enabl
develop
recombin
vaccin
display
undesir
resist
antibiot
santand
et
al
also
report
e
tarda
e
ictaluri
possess
inact
asdb
gene
present
activ
form
gramposit
bacteria
also
vibrio
speci
asda
asdb
attenu
crp
santand
et
al
fur
mutat
render
e
ictaluri
attenu
immunogen
catfish
ictaluru
punctatu
wang
et
al
describ
encod
part
gene
ese
operon
essenti
e
tarda
virul
ese
protein
use
induc
protect
immun
e
tarda
challeng
turbot
steven
et
al
oral
immun
cat
l
monocytogen
strain
felin
immunodefici
viru
fiv
gene
encod
gag
chromosom
integr
env
dna
vaccin
vector
signific
siga
titer
detect
vagin
secret
three
five
immun
cat
five
cat
challeng
fiv
immun
also
significantli
reduc
fiv
titer
follow
vagin
challeng
followup
studi
steven
et
al
employ
system
show
cat
previous
immun
l
monocytogen
vector
control
could
still
product
oral
immun
recombin
strain
deliv
gag
dna
vaccin
encod
env
induc
siga
antibodi
vagin
secret
saliva
fece
zhao
et
al
use
dalanin
requir
l
monocytogen
strain
deliv
antigen
observ
one
strain
induct
mice
protect
mucos
antibodi
cellular
respons
measur
challeng
gagencod
recombin
vaccinia
viru
vector
observ
induct
high
number
gagspecif
cell
malt
follow
oral
vaccin
signific
jiang
et
al
also
use
dalanin
requir
l
monocytogen
strain
deliv
hivgag
antigen
chromosom
encod
insert
sepa
gene
oral
vaccin
rhesu
monkey
dose
cfu
oral
administ
whip
cream
three
two
interv
group
get
two
oral
dose
week
zero
six
receiv
intramuscular
dose
cfu
week
dalanin
administ
iv
min
h
vaccin
mucos
immun
detect
vagin
intestin
tetanu
toxin
c
l
lactu
grangett
et
al
c
tetani
tetanu
toxin
c
l
plantarum
grangett
et
al
c
tetani
tetanu
toxin
c
l
plantarum
reveneau
et
al
etec
gfpstltb
l
reuteri
wu
chung
qiu
et
al
use
attenu
l
monocytogen
mutant
alter
prfa
gene
yan
et
al
caus
constitut
express
prf
prfregul
gene
increas
secret
recombin
antigen
vivo
deliv
hivgag
bacillu
anthraci
pa
immun
mice
rout
immun
superior
parenter
rout
immun
induc
mucos
well
cellular
immun
respons
pulmonari
tract
efficaci
iv
vaccin
stimul
system
cellular
immun
respons
yu
et
al
parenter
immun
mice
recombin
smegmati
strain
secret
env
primeboost
regimen
induc
signific
level
cellular
immun
hiv
lung
recent
sweeney
et
al
describ
muchimprov
smegmati
vector
protect
tuberculosi
infect
use
vector
deliv
protect
antigen
pathogen
vasconcello
et
al
construct
smegmati
bcg
strain
deliv
epec
intimin
bfpa
bundleform
pilu
antigen
construct
use
oral
immun
mice
develop
serum
igg
iga
well
fecal
iga
intimin
bfpa
adhes
virul
epec
strain
cell
block
either
induc
antiintimin
antibfpa
iga
igg
antibodi
jensen
et
al
describ
replicationdefici
recombin
attenu
tuberculosi
strain
mc
ranganathan
et
al
mutat
plasmidspecifi
siv
gag
deliv
oral
without
id
boost
total
safe
sivinfect
infant
macaqu
import
sinc
licens
bcg
vaccin
caus
dissemin
diseas
hiv
infect
children
manuscript
use
mucos
deliveri
measur
mucos
immun
antibodi
cellular
recombin
bcg
vaccin
cite
discuss
note
howev
dennehi
williamson
care
review
mani
public
indic
abil
bcgbase
vaccin
elicit
strong
mucos
immun
respons
mice
guinea
pig
administ
oral
intragastr
rectal
rout
administ
parenter
kawahara
et
al
construct
recombin
bcg
synthes
env
peptid
oral
immun
guinea
pig
develop
intestin
intraepitheli
cell
lymphocyt
well
antigenspecif
cell
system
compart
memori
fulli
detect
year
oral
immun
mederl
et
al
use
mixtur
three
recombin
bcg
vaccin
deliv
siv
gag
env
nef
rbcgsiv
vaccin
mixtur
initi
use
intraderm
vaccin
five
site
back
macaqu
follow
week
later
either
three
intragastr
vaccin
three
intrarect
vaccin
regimen
result
signific
antisiv
iga
rectal
lavag
fluid
wang
et
al
compar
two
recombin
bcg
strain
plasmidspecifi
chromosomalintegr
rhomboid
proteas
gene
coccidiosiscaus
eimeria
tenella
intranas
vaccin
chicken
immun
chicken
display
increas
serum
antibodi
titer
importantli
oral
challeng
oocyst
show
signific
reduct
intestin
lesion
score
weight
loss
shed
oocyst
fece
addit
consider
evalu
local
mucos
immun
respons
induc
mycobacteria
tuberculosi
mycobacteria
see
chapter
j
ivanyi
book
salmonelladeriv
rabv
remain
extens
develop
studi
howev
view
signific
mucos
cellular
immun
respons
induc
listeriaand
mycobacteriumvector
vaccin
unfortun
effort
focus
studi
induct
mucos
cellular
immun
respons
salmonellavector
vaccin
digiandomenico
et
al
use
aroa
typhimurium
strain
induc
mucos
system
immun
respons
p
aeruginosa
lp
antigen
oral
immun
observ
signific
protect
immun
later
studi
digiandomenico
et
al
use
immun
mice
howev
induc
signific
protect
immun
thu
rout
immun
impact
degre
success
confer
protect
immun
result
mandat
need
develop
attenu
strategi
preclud
salmonella
deliv
rout
travers
brain
bollen
et
al
altern
might
investig
use
sublingu
immun
cuburu
et
al
rasv
strain
often
use
deliv
recombin
protect
protein
antigen
often
specifi
sequenc
codon
optim
highlevel
express
salmonella
rare
case
code
sequenc
modifi
remov
stemloop
structur
mrna
reduc
nucleas
attack
increas
mrna
halflif
regard
becher
et
al
use
recombin
aroa
typhimurium
strain
synthes
helicobact
pylori
urea
b
oral
immun
mice
demonstr
induct
increas
popul
cell
neutrophil
gastric
mucosa
reduct
treg
cell
collect
led
reduc
titer
h
pylori
challeng
thu
evid
rasv
abl
induc
protect
mucos
immun
respons
stomach
compart
gastrointestin
tract
induct
protect
immun
respons
urinari
tract
report
scavon
et
al
use
tetc
fusion
p
mirabili
mannoseresist
fimbria
subunit
mrpa
induc
immun
respons
significantli
reduc
titer
p
mirabili
bladder
kidney
immun
mice
describ
earlier
section
list
tabl
extens
modifi
rasv
strain
enhanc
safeti
immunogen
deliv
multipl
protect
pneumococc
antigen
mice
see
curtiss
et
al
wang
et
al
object
develop
vaccin
oral
administ
newborn
would
protect
pneumonia
serotyp
might
encount
anywher
world
mani
improv
strategi
also
use
improv
abil
rasv
induc
protect
immun
pneumon
bubon
plagu
tabl
rasv
extens
use
develop
vaccin
diarrheal
diseas
also
effect
cariogen
periodont
pathogen
least
rodent
see
tabl
rasv
begun
use
develop
vaccin
parasit
infect
case
parasit
resid
proxim
mucos
surfac
invad
surfac
particularli
import
develop
rasv
protect
intestin
protozoan
parasit
giardia
lamblia
jenikova
et
al
although
rasv
also
use
vaccin
vector
insectborn
parasit
exampl
ignor
chapter
sinc
evid
mucos
immun
would
import
confer
protect
use
rasv
deliv
viral
antigen
given
mix
result
viral
protect
protein
antigen
requir
glycosyl
antibodi
induc
gener
nonneutr
nonprotect
virus
without
glycosyl
capsid
protein
sometim
assembl
capsomer
structur
even
viruslik
particl
vlp
highli
immunogen
antibodi
respons
usual
confer
protect
immun
work
well
human
papilloma
viru
hpv
baud
et
al
assembl
woodchuck
hepat
core
antigen
influenza
fusion
ameiss
et
al
hand
deliv
nucleocapsid
antigen
often
effect
induc
protect
cellular
immun
unfortun
examin
cellular
immun
mucos
tissu
often
evalu
sinc
mucos
rout
immun
invari
optim
mean
induc
immun
respons
measur
chiu
et
al
use
rasv
deliv
enteroviru
ev
femal
mice
week
prior
mate
picornaviru
capsid
glycosyl
inform
provid
whether
capsid
protein
assembl
salmonella
form
vlp
newborn
mice
partial
protect
lowdos
lethal
challeng
highdos
lethal
challeng
ev
unimmun
vectorimmun
infant
mice
succumb
either
dose
tsunetsuguyokota
et
al
construct
rasv
use
aroa
typhimurium
deliv
human
immunodefici
viru
hiv
gag
synthes
codonoptim
sequenc
puc
ori
vector
highlevel
gene
express
salmonella
oral
immun
led
low
level
mucos
iga
nasal
intestin
secret
serum
igg
antibodi
cytotox
lymphocyt
ctl
also
induc
mucos
surfac
tissu
well
intern
lymphoid
tissu
issu
inabl
salmonella
glycosyl
gag
address
therefor
highli
dubiou
antibodi
respons
induc
signific
potenti
confer
protect
infect
contrast
induc
ctl
might
confer
protect
luo
et
al
insert
sever
acut
respiratori
syndrom
sar
viru
n
gene
chromosom
pilv
gene
gale
typhi
strain
synthesi
n
antigen
control
type
iv
pilu
operon
rasv
administ
ip
oral
iv
rout
rout
induc
highest
mucos
iga
serum
igg
antin
antibodi
titer
also
highest
ctl
respons
spleen
evalu
kill
sar
nexpress
tumor
cell
line
report
liljebjelk
et
al
show
protect
chicken
influenza
challeng
immun
rasv
strain
synthes
ha
nonglycosyl
larg
insolubl
difficult
understand
data
whether
antibodi
neutral
provid
similar
experi
done
year
ago
collabor
major
influenza
research
group
rasv
produc
ha
protein
fail
induc
neutral
antibodi
fail
show
specif
immun
protect
influenza
challeng
therefor
discontinu
research
deliveri
antigen
would
requir
glycosyl
sinc
would
like
antibodi
induc
would
effect
confer
protect
immun
echchannaoui
et
al
use
rasv
deliv
intravagin
immun
mice
vaccin
somewhat
inflammatori
induc
mucos
system
antibodi
respons
protect
mice
prolifer
tumor
result
intravagin
immun
essenti
observ
earlier
oral
immun
baud
et
al
mani
mean
attenu
salmonella
retain
immunogen
describ
previou
review
list
introduct
yqic
newli
identifi
protein
high
content
coiledcoil
structur
permit
trimer
display
fusogen
activ
membran
carrica
et
al
absenc
lead
attenu
even
though
retain
abil
invad
replic
epitheli
cell
macrophag
gene
gene
product
certainli
deserv
studi
regard
effect
immunogen
hur
lee
use
typhimurium
strain
secret
ltb
fuse
ss
asda
vector
demonstr
signific
adjuv
effect
increas
serum
especi
mucosa
antibodi
respons
level
induc
strain
releas
ltb
adjuv
strain
also
exhibit
biolog
contain
featur
failur
detect
viabl
bacteria
time
oral
immun
studi
develop
mixtur
vaccin
deliv
secret
fasa
pilin
plu
intimin
hur
lee
also
fail
detect
viabl
vaccin
cell
excret
fece
time
examin
extent
durat
vaccin
cell
viscer
tissu
subsequ
studi
demonstr
complet
protect
pig
diarrheal
diseas
caus
mixtur
etec
challeng
strain
caus
sever
diseas
control
unvaccin
pig
lee
vaccin
display
contain
featur
observ
mice
attenu
lon
cpxr
mutat
adequ
investig
rel
enhanc
antigen
deliveri
effect
versu
respons
importantli
induc
mucos
antibodi
cellular
immun
respons
influenc
alter
synthesi
modif
salmonella
pamp
interact
variou
tlr
nod
factor
well
studi
term
enhanc
desir
mucos
antibodi
cellular
immun
respons
gat
et
al
observ
paratyphi
strain
intact
flagella
induc
much
better
immun
respons
immun
mice
strain
produc
flic
flagellin
without
assembl
flagella
howev
roja
et
al
compar
typhimurium
rasv
strain
deliv
nontox
without
flagella
observ
differ
mucos
system
antibodi
titer
induc
gener
featur
use
rasv
stimul
protect
immun
respons
griffin
mcsorley
found
gener
salmonellaspecif
cell
requir
sustain
antigen
stimul
minimum
week
use
interrupt
immun
process
antibiot
therapi
regul
durat
vaccin
strain
persist
mice
methodolog
could
numer
applic
achiev
better
understand
induct
differ
immun
respons
rabv
galen
et
al
develop
use
typhi
cytolysin
hemolysin
mean
export
protect
antigen
vaccin
cell
supernat
demonstr
use
b
anthraci
pa
antigen
induct
significantli
higher
level
immun
immun
mice
observ
pa
secret
bailli
et
al
compar
deliveri
b
anthraci
pa
antigen
use
hlya
hemolysin
clya
export
system
licens
typhi
vaccin
use
immun
mice
deliveri
pa
via
clya
system
superior
investig
found
recombin
vaccin
effect
prime
signific
immun
respons
pa
administ
parenter
later
time
schifferli
compar
deliveri
tgev
spike
epitop
fusion
subunit
fimbria
versu
use
misl
autotransport
sever
attenu
typhimurium
strain
although
antibodi
titer
epitop
higher
misl
display
system
neutral
antibodi
titer
higher
fimbrial
present
system
thu
present
must
influenc
conform
sinc
misl
fusion
construct
synthes
time
higher
level
fusion
construct
autotransport
investig
time
mean
export
present
antigen
cell
surfac
see
curtiss
system
transmembran
extern
domain
may
may
cleav
releas
proteas
ompt
one
preclud
releas
delet
basic
amino
acid
hing
region
hbp
autotransport
studi
jong
et
al
secret
display
heterolog
antigen
attenu
typhimurium
tuberculosi
differ
two
amino
acid
autotransport
tsh
first
autotransport
identifi
enterobacteriacea
provenc
curtiss
hbp
tsh
bind
heme
digest
hemoglobin
thu
contribut
septicemia
caus
expec
strain
concern
bacterialvector
vaccin
whether
individu
immun
alreadi
expos
pathogen
one
close
relat
one
vaccin
vector
deriv
case
individu
might
respond
elicit
signific
immun
respons
deliv
protect
recombin
antigen
also
issu
toler
bacteri
antigen
deliveri
vector
potenti
problem
discuss
use
commens
bacteri
strain
antigendeliveri
vector
metzger
et
al
evalu
question
use
human
volunt
typhi
without
deliveri
plasmidencod
h
pylori
urea
b
subunit
studi
prior
immun
exist
antibodi
salmonella
lp
alter
frequenc
individu
show
cellular
immun
respons
urea
b
subunit
attridg
vindurampul
also
review
issu
therefor
examin
whether
mice
prime
oral
immun
stanley
serotyp
natur
attenu
mice
transient
colon
pp
liver
spleen
would
lessen
immun
respons
pilu
antigen
deliv
later
recombin
stanley
strain
case
even
prime
ip
rout
immun
respons
base
antibodi
product
mute
immun
prime
mice
recombin
vaccin
anticip
potenti
problem
repeat
use
vaccin
vector
multipl
vaccin
protect
divers
pathogen
see
curtiss
et
al
commenc
modifi
salmonella
antigendeliveri
vector
elimin
reduc
synthesi
immunodomin
serotypespecif
surfac
antigen
vivo
hope
diminish
induct
antibodi
respons
evalu
strain
typhimurium
typhi
shi
et
al
observ
prior
immun
potenti
mother
week
breed
gave
rise
pup
mount
immun
ident
rasv
day
age
higher
level
immun
respons
higher
level
protect
immun
pup
nonimmun
mother
studi
yet
complet
prior
immun
rasv
deliv
one
heterolog
protect
antigen
advers
effect
induct
immun
respons
rasv
vector
deliv
differ
heterolog
protect
antigen
salam
et
al
use
mice
immun
rout
rasv
deliv
nonsecret
portion
mutan
salivabind
protein
sbp
signal
enhanc
serum
immun
respons
sbp
wherea
respons
salmonella
lp
benefit
signal
via
howev
mucos
iga
respons
sbp
mucos
iga
respons
salmonella
park
et
al
found
signal
essenti
induc
pspaspecif
bcell
respons
lead
mucos
serum
antibodi
essenti
induc
protect
immun
pneumonia
challeng
li
et
al
describ
construct
recombin
attenu
flexneri
strain
express
hpv
protein
use
intraocular
vaccin
guinea
pig
vaccin
protect
guinea
pig
shigellainduc
keratoconjunct
led
signific
induct
iga
antibodi
secret
cell
spleen
lymph
node
suzuki
et
al
describ
potenti
much
improv
flexneri
vaccin
vector
elimin
mean
shigella
invad
epitheli
cell
result
excess
inflamm
delet
ipab
gene
substitut
use
yersinia
pseudotuberculosi
inv
gene
promot
invas
cell
bronchusassoci
lymphoid
tissu
balt
galt
mice
vaccin
vaccin
strain
produc
high
titer
serum
iga
igg
antibodi
lp
low
titer
inflammatori
cytokin
protect
flexneri
challeng
although
suitabl
attenu
deriv
pseudotuberculosi
enterocolitica
gener
valid
safe
oral
administ
vaccin
use
recombin
mode
often
use
effect
deliv
viral
parasit
antigen
stimul
protect
immun
littl
attent
whether
would
induc
signific
mucos
immun
respons
unfortun
sinc
system
develop
might
profici
induc
cellular
immun
mucos
compart
lung
well
induc
product
mucos
iga
respons
invas
might
also
engend
induct
longterm
protect
mucos
immun
respons
clostridium
nonattenu
c
perfringen
engin
synthes
plasmidspecifi
gag
protein
use
oral
immun
mice
combin
vlp
oral
adjuv
cholera
toxin
ct
mutant
heatlabil
toxin
mlt
cpg
induc
vagin
serum
antibodi
respons
cell
respons
hiv
antigen
pegu
et
al
sinc
immun
respons
bare
signific
use
recombin
c
perfringen
strain
alon
significantli
elev
vlp
administ
either
recombin
c
perfringen
strain
unclear
role
noninvas
bacteri
host
induc
report
result
howev
chen
et
al
previous
observ
fusion
protein
produc
c
perfringen
present
dendrit
cell
dc
pp
follow
oral
immun
mice
also
clear
whether
strain
use
pegu
et
al
produc
enterotoxin
could
facilit
antigen
present
vlp
mean
hiv
antigen
releas
bacteri
cell
taken
dc
galt
westendorf
et
al
describ
use
probiot
e
coli
strain
nissl
vector
deliv
ha
epitop
influenza
viru
harm
et
al
genet
modifi
nonpathogen
e
coli
express
genet
sequenc
encod
invasin
pseudotuberculosi
listeriolysin
l
monocytogen
exhibit
invas
intracellular
releas
antigen
use
green
fluoresc
protein
gfp
model
antigen
demonstr
induct
predomin
respons
product
ctl
ultim
aim
deliv
antigen
brucella
examin
induct
mucos
immun
zhu
et
al
use
mutant
epec
strain
caus
diarrheal
diseas
rabbit
use
deliv
plasmodium
circumsporozoit
nanp
antigen
toxin
subunit
employ
e
coli
hemolysin
export
system
misl
autotransport
salmonella
biliari
iga
serum
igg
induc
antigen
protect
antigen
deliv
cell
surfac
secret
hemolysi
system
oral
administr
construct
also
induc
protect
challeng
virul
rdec
strain
marshal
schoep
review
effort
far
unsuccess
develop
attenu
h
pylori
antigen
deliveri
strategi
induc
protect
immun
pathogen
lactobacillu
lactococcu
strain
administ
oral
often
gastric
intub
rel
larg
amount
mg
wet
weight
mg
dri
weight
cfu
per
mous
given
day
row
week
one
two
four
boost
everi
two
three
week
thu
total
dose
probabl
approxim
bacteria
entir
oral
immun
regimen
mani
recent
studi
use
immun
lower
dose
often
better
result
bacteria
grow
optim
lower
mammalian
avian
bodi
temperatur
l
lacti
l
casei
persist
establish
commens
oral
immun
anim
host
wherea
speci
grow
l
plantarum
l
acidophilu
l
helveticu
persist
longer
issu
address
concern
use
bacteri
vaccin
vector
select
strain
potenti
commens
thu
induc
immunolog
toler
high
repetit
dose
need
induc
desir
immun
respons
would
seem
favor
outcom
grangett
et
al
compar
plasmid
encod
synthesi
deliveri
tetanu
toxin
fragment
c
l
lacti
persist
colon
intestin
tract
mice
l
plantarum
recombin
l
plantarum
best
uvirradi
construct
also
inferior
live
viabl
strain
mice
immun
intragastr
cfu
three
consecut
day
two
three
repeat
immun
three
week
apart
conclus
base
induc
serum
igg
level
neutral
tetanu
toxin
reveneau
et
al
compar
three
l
plantarum
strain
either
retain
tetanu
toxin
fragment
c
cytoplasm
secret
display
cellsurfac
expos
three
recombin
vaccin
strain
administ
mice
intragastr
sc
rout
rout
induc
signific
antitoxin
antibodi
strain
cell
surfac
local
fragment
c
requir
lowest
dose
induc
antibodi
highest
antibodi
titer
observ
strain
cytoplasm
local
antigen
grangett
et
al
gener
alanin
racemas
defici
l
lacti
l
plantarum
strain
found
superior
induc
antitoxin
c
antibodi
l
plantarum
strain
superior
especi
induc
antitoxin
iga
respons
intestin
secret
thu
lysi
releas
synthes
antigen
superior
mean
antigen
deliveri
especi
induc
mucos
immun
adachi
et
al
introduc
plasmid
encod
mutat
form
protein
render
nontumorogen
retain
immunogen
protein
sugarappl
isol
l
casei
strain
grown
antibiot
select
attenu
heat
cell
wash
sever
time
distil
water
dri
powder
store
dri
powder
suspend
phosphatebuff
salin
pb
administ
intragastr
tube
mice
fast
h
mice
immun
day
week
week
one
two
four
eight
vaccin
induc
signific
proport
integrin
cell
intestin
mucos
lymphocyt
cell
exhibit
ctl
activ
taguchi
et
al
extend
studi
demonstr
coadministr
two
differ
japanes
herbal
medicin
recombin
heatinactiv
l
casei
strain
enhanc
mucos
cellular
immun
respons
yoon
et
al
chose
deliv
amino
acid
induc
crossreact
antibodi
would
prophylact
hpv
type
synthetas
protein
b
subtili
use
achiev
surfac
display
sequenc
l
casei
repetit
use
immun
mice
intragastr
lavag
serum
igg
vagin
igg
iga
induc
use
bovin
pseudovirion
demonstr
neutral
activ
hpv
pseudovirion
sera
bovin
papilloma
viru
bpv
immun
mice
show
neutral
activ
cortesperez
et
al
compar
deliveri
plasmidspecifi
l
lacti
l
plantarum
use
intragastr
immun
rout
superior
term
induc
serum
igg
mucos
iga
therapeut
reduc
growth
tumor
also
l
plantarum
strain
outperform
l
lacti
strain
oliveira
et
al
initi
introduc
pneumonia
psaa
encod
sequenc
l
lacti
l
casei
l
plantarum
l
helveticu
replac
signal
sequenc
lipid
site
fusion
ss
recombin
l
lacti
least
abl
colon
vaccin
elicit
lowest
level
antipsaa
antibodi
compar
strain
lactobacillu
speci
thu
superior
colon
induct
immun
respons
l
plantarum
l
helveticu
strain
capabl
grow
give
best
antibodi
result
result
accord
find
grangett
et
al
discuss
thu
surpris
oliveira
group
subsequ
work
well
group
continu
focu
use
l
casei
strain
note
wang
et
al
found
fulllength
psaa
signal
sequenc
lipid
signal
abl
induc
immun
block
pneumococc
colon
upper
respiratori
tract
mice
wherea
deliveri
truncat
form
psaa
unabl
induc
protect
campo
et
al
oliveira
group
thu
express
constitut
pneumonia
sequenc
encod
domain
prolinerich
region
pspa
gene
lack
signal
sequenc
plasmid
vector
l
casei
administ
mice
two
dose
cfu
serum
igg
respons
induc
antibodi
abl
coat
surfac
number
pspa
clade
strain
modest
level
protect
immun
lowdos
ip
challeng
pneumonia
observ
recombin
l
casei
persist
nasal
mucosa
day
induct
mucos
immun
respons
monitor
work
expand
also
deliv
domain
pspc
gene
ferreira
et
al
immun
six
dose
cfu
l
casei
strain
deliv
pspc
result
protect
immun
hernani
mde
et
al
extend
work
demonstr
immun
recombin
l
casei
strain
deliv
pspc
reduc
intranas
colon
pneumonia
challeng
result
detect
intranas
iga
respons
describ
xin
et
al
xin
et
al
xin
et
al
observ
signific
protect
immun
sever
pneumonia
strain
differ
challeng
rout
deliveri
attenu
salmonella
vaccin
pspa
pspc
alon
togeth
fusion
repres
divers
epitop
domain
prolinerich
region
divers
pneumococc
serotyp
medina
et
al
deliv
pneumonia
pppa
surfac
protein
export
signal
sequenc
cell
wall
protein
cell
surfac
l
lacti
nisininduc
cultur
use
immun
led
induct
serum
mostli
igg
bronchial
alveolar
lavag
fluid
mostli
iga
antipppa
antibodi
mice
protect
lethal
ip
challeng
pneumonia
strain
pppa
gene
clone
wu
chung
use
l
rueteri
deliv
secret
green
fluoresc
protein
coli
heatstabl
toxin
coli
heatlabil
toxin
subunit
b
gfpstltb
fusion
possess
gm
gangliosid
bind
abil
repetit
oral
immun
mice
induc
fecal
mucos
iga
serum
igg
protect
mice
oral
challeng
stand
ltproduc
etec
strain
use
nisininduc
expressionsecret
vector
pni
liu
et
al
use
plasmid
vector
encod
synthetas
protein
b
subtili
hou
et
al
enabl
cell
surfac
display
etec
fimbrial
antigen
l
casei
cell
repetit
oral
immun
led
high
titer
mucos
iga
serum
igg
skew
vaccin
mice
challeng
lethal
dose
etec
strain
clear
infect
intestin
tract
surviv
wei
et
al
also
use
synthetas
anchor
system
display
pilin
surfac
l
casei
cell
oral
immun
mice
induc
mucos
iga
serum
igg
antibodi
mice
immun
either
rout
display
protect
oral
challeng
etec
strain
studi
includ
induct
protect
immun
surfac
display
pilin
subunit
antigen
deliveri
l
casei
fimbrial
antigen
report
wen
et
al
chu
et
al
construct
fusion
gene
slayer
gene
l
acidophilu
express
plasmid
vector
control
constitut
slayer
protein
promot
recombin
l
acidophilu
unlik
l
casei
l
lacti
grow
use
colon
pig
oral
administr
antigen
found
cell
surfac
supernat
recombin
adher
intestin
brush
border
competit
displac
etec
strain
fimbria
induct
immun
respons
report
corthesi
et
al
use
l
plantarum
alr
mutant
deliv
plasmidspecifi
ureas
b
subunit
h
feli
mice
use
intragastr
immun
cfu
day
row
repeat
two
addit
time
week
apart
antiureas
serum
iga
igg
induc
h
feli
titer
significantli
reduc
immun
mice
del
rio
et
al
express
synthesi
borrelia
burgdorferi
ospa
gene
without
codon
optim
plasmid
vector
l
plantarum
grown
harvest
frozen
later
recov
administ
cfu
oral
gavag
given
twice
daili
day
mice
colon
transient
sinc
bacteria
recov
h
last
inocul
antiospa
fecal
iga
serum
igg
induc
mice
protect
ticktransmit
b
burgdorferi
infect
subsequ
paper
del
rio
et
al
effect
lipid
ospa
care
analyz
reveal
bia
nonlipid
ospa
deliv
l
plantarum
vaccin
vector
del
rio
et
al
use
l
plantarum
vaccin
vector
deliv
pesti
lcrv
antigen
without
fusion
b
burgdorferi
ospa
protein
enabl
lcrv
cellsurfac
local
mucos
iga
serum
igg
induc
evid
protect
immun
pestiscaus
pneumon
bubon
plagu
pseudotuberculosi
entercolitica
provid
achiev
attenu
salmonellavector
vaccin
branger
et
al
branger
et
al
geriletu
et
al
use
l
casei
deliv
surfac
protein
cryptosporidium
parvum
oral
immun
mice
fast
mice
receiv
cfu
three
consecut
day
week
develop
fecal
iga
serum
igg
respons
inform
challeng
studi
report
ho
et
al
constitut
synthes
ntermin
sequenc
protect
tgev
coronaviru
glycosyl
spike
protein
secret
surfac
recombin
l
casei
strain
construct
dose
cfu
administ
daili
day
repeat
twice
interv
particular
strain
seem
persist
higher
titer
variou
intestin
compart
strain
use
other
induc
good
fecal
iga
serum
igg
titer
importantli
inhibit
transmiss
gastroenter
viru
tgev
plaqu
format
monolay
swine
testicular
cell
earlier
deliv
tgev
protein
attenu
typhimurium
vaccin
smerdou
et
al
oral
immun
mice
induc
mucos
iga
serum
igg
respons
virusneutr
unpublish
improv
strategi
employ
fuse
dna
sequenc
encod
multim
amino
acid
protect
sgene
epitop
ctermin
end
ltb
signal
sequenc
intact
smerdou
et
al
vaccin
strain
use
oral
immun
rabbit
induc
intestin
iga
serum
igg
titer
suffici
neutral
tgev
although
inabl
bacteria
glycosyl
viral
protein
often
preclud
induc
protect
immun
respons
result
ho
et
al
would
suggest
secret
antigen
recombin
vaccin
vector
like
yield
protect
immun
lee
et
al
develop
protect
antigen
surfac
display
system
use
synthetas
protein
bacillu
subtili
encod
pgsa
gene
enabl
present
sar
spike
protein
amino
acid
segment
segment
b
l
casei
administ
repetit
intragastr
induc
high
titer
intestin
lung
mucos
iga
serum
igg
oral
immun
yield
higher
titer
serum
intestin
antibodi
abl
neutral
sar
pseudovirus
immun
studi
also
identifi
three
new
neutral
epitop
hou
et
al
also
use
synthetas
protein
b
subtili
anchor
nucleocapsid
protein
porcin
epidem
diarrheal
viru
pedv
surfac
recombin
l
casei
repetit
oral
dose
eight
dose
immun
mice
yield
induct
serum
igg
lung
iga
sow
immun
addit
heatkil
recombin
l
casei
feed
result
high
igg
iga
titer
colostrum
abl
neutral
viru
prevent
plaqu
format
surfac
display
attribut
vaccin
like
basi
success
liu
et
al
use
plasmid
vector
cell
surfac
display
pgsa
gene
b
subtili
signal
sequenc
caus
export
pedv
n
protein
l
casei
cell
mice
repetit
immun
oral
mucos
iga
antibodi
measur
nasal
wash
ophthalm
fluid
intestin
wash
vagin
fluid
highest
titer
induc
strain
deliv
n
antigen
surfac
display
antigen
serum
igg
respons
abl
neutral
viru
shown
reduct
plaqu
format
kajikawa
et
al
construct
recombin
l
casei
strain
surfaceexpos
flic
enteritidi
repetit
nine
dose
intragastr
immun
mice
cfu
although
flagellinspecif
iga
igg
respons
observ
mice
produc
flicinduc
protect
enteritidi
lethal
challeng
result
thu
suggest
protect
due
induct
cellular
immun
followup
studi
kajikawa
igimi
fuse
enteritidi
sipc
ctermin
end
surfaceloc
flic
observ
induct
antibodi
sipc
flic
predomin
respons
kajikawa
et
al
surfacedisplay
hiv
gag
typhimurium
flic
recombin
l
acidophilu
strain
fusion
signal
sequenc
anchor
motif
mucusbind
protein
flic
interact
hek
cell
trigger
synthesi
repetit
intragastr
immun
led
serum
igg
mucos
iga
much
higher
titer
especi
mucos
iga
induc
strain
also
display
flic
mohamadzadeh
et
al
describ
construct
surfaceexpos
antigen
deliveri
system
specif
target
via
dcbind
peptid
dc
resid
intestin
mucosa
peripher
tissu
studi
plasmid
sequenc
encod
b
anthraci
pa
engin
secret
dc
target
ctermin
fusion
amino
acid
dctarget
nontarget
peptid
plasmidcontain
l
acidophilu
strain
fulli
evalu
mice
repetit
gastric
intub
strain
dctarget
peptid
induc
pa
neutral
antibodi
intestin
iga
importantli
protect
ip
challeng
b
anthraci
stern
work
also
fulli
describ
review
mohamadzadeh
intragastr
immun
mice
l
casei
strain
deliv
porcin
parvoviru
induc
mucos
iga
serum
igg
capabl
neutral
porcin
parvoviru
subsequ
studi
xu
et
al
also
includ
strong
ctl
epitop
classic
swine
fever
viru
csfv
addit
antigen
importantli
mucos
system
ctl
respons
induc
csfv
raha
et
al
use
ctermin
sequenc
one
three
amino
acid
repeat
nacetylmuraminidas
l
lacti
specif
caus
tight
cell
wall
bind
peptid
sequenc
fuse
repeat
construct
made
use
ntermin
sequenc
protein
enteroviru
protein
product
synthes
e
coli
use
bind
l
lacti
cell
test
stabil
immun
report
saez
et
al
use
secret
vector
deliv
periplasm
superoxid
dismutas
cu
zn
cofactor
cu
zn
sod
b
abortu
l
lacti
use
oral
immun
mice
sodspecif
iga
induc
nasal
bronchoalveolar
lavag
fluid
sodspecif
igg
serum
immun
mice
caus
reduct
b
abortu
titer
challeng
antigenspecif
cell
prolifer
equal
week
month
complet
immun
regimen
thu
memori
induc
wang
et
al
report
induct
mucos
iga
serum
igg
ha
avian
influenza
viru
deliv
recombin
l
delbrueckii
strain
oral
administ
chicken
data
viru
neutral
given
mention
made
glycosyl
ha
nevertheless
mani
studi
use
lactobacillu
antigen
deliveri
strategi
especi
secret
surfac
display
releas
lysi
gave
promis
result
induc
mucos
immun
protect
challeng
ludi
et
al
endow
attenu
v
cholera
vaccin
abil
synthes
assembl
etec
colon
antigen
specifi
plasmid
confer
antibiot
resist
fimbria
visual
cell
surfac
electron
microscopi
neg
stain
tobia
et
al
also
construct
nonct
produc
v
cholera
strain
abil
synthes
etec
specifi
plasmid
thya
gene
complement
chromosom
thya
mutat
thu
yield
antibioticsensit
vaccin
strain
formalinkil
prepar
use
oral
immun
roland
et
al
construct
deriv
attenu
v
cholera
vaccin
strain
oversynthes
secret
ctb
balancedleth
plasmid
construct
yield
antibioticsensit
recombin
vaccin
strain
intranas
immun
mice
oral
immun
rabbit
result
antictbb
titer
time
induc
parent
strain
serum
antibodi
neutral
ct
mucos
iga
titer
determin
xiao
et
al
use
attenu
vibrio
anguillarum
strain
virul
plasmid
cure
evalu
variou
plasmid
replicon
result
select
plasmid
putat
replicon
deriv
stabl
vitro
vivo
gapdh
gene
e
tarda
clone
plasmid
vector
specifi
antibiot
resist
transform
vaccin
strain
evalu
intracoelom
ic
immun
although
partial
protect
challeng
e
tarda
turbot
observ
use
mucos
immun
investig
result
deliveri
attenu
bacteria
protect
antigen
synthesi
capabl
encod
dna
vaccin
vector
often
mislead
problem
compound
use
high
copi
number
puc
ori
replicon
commerci
avail
dna
vaccin
vector
make
use
cytomegaloviru
cmv
promot
drive
express
insert
dna
sequenc
eukaryot
immun
host
select
marker
sequenc
express
bacteri
host
often
recogn
express
gene
clone
high
copi
number
vector
need
promot
kang
et
al
thu
one
get
express
sequenc
express
control
cmv
promot
immun
anim
host
bacteri
strain
prior
immun
complic
matter
bacteri
rna
polymeras
transcrib
sequenc
thousand
bp
promot
one
associ
select
marker
thu
unless
one
strong
transcript
termin
either
side
eukaryot
express
cassett
bacteri
synthes
antisens
mrna
preclud
express
cmv
promoterassoci
code
sequenc
kong
et
al
one
like
presynthes
protect
antigen
present
rabv
immun
deliveri
dna
vaccin
desir
encod
product
glycosyl
cell
immun
host
often
mixtur
antigen
synthes
bacteri
vaccin
cell
nonglycosyl
result
mix
immun
respons
rather
one
high
specif
problem
address
care
design
dna
vaccin
vector
care
use
transcript
termin
stop
codon
direct
transcript
variou
code
sequenc
use
attenu
bacteri
vector
deliv
dna
vaccin
potenti
benefit
vector
strain
administ
mucos
portal
entri
like
induct
mucos
antibodi
cellular
immun
respons
unfortun
mucos
respons
rigor
quantifi
shown
due
deliveri
dna
vaccin
deliveri
preform
antigen
discuss
decid
use
dna
vaccin
deliveri
system
much
depend
pathogen
type
vaccin
design
protect
sinc
bacteria
glycosyl
gene
product
except
deliveri
bacteri
gene
encod
protect
antigen
wise
choic
unless
shown
gene
product
synthes
bacteria
suitabl
eukaryot
cell
posttransl
modif
eukaryot
cell
would
lead
induct
nonprotect
immun
respons
elsewher
book
raska
turanek
discuss
induct
mucos
immun
dna
vaccin
administ
nake
dna
plasmid
mani
paper
describ
construct
attribut
dna
vaccin
focu
deliveri
recombin
attenu
bacteri
strain
nevertheless
number
review
montgomeri
prather
brandsma
william
et
al
carn
et
al
provid
use
guidanc
although
address
uniqu
problem
associ
deliveri
rabv
vector
thu
one
import
issu
concern
elimin
sequenc
dna
vaccin
vector
subject
nucleas
attack
either
bacteri
deliveri
strain
immun
host
also
critic
import
inclus
enhanc
nuclear
target
sequenc
improv
express
dna
vaccin
encod
sequenc
addit
featur
bacteri
deliveri
vector
also
critic
import
thu
best
releas
dna
vaccin
lysi
rabv
prefer
host
cell
cytosol
elimin
bacteri
nucleas
inclus
appropri
mutat
sinc
mani
bacteria
induc
apoptosispyroptosi
eukaryot
cell
invad
sinc
event
would
decreas
abil
nucleu
transcrib
dna
vaccin
encod
sequenc
one
must
lessen
abil
vaccin
vector
induc
apoptosispyroptosi
one
also
alter
display
pamp
recruit
desir
innat
immun
respons
regard
li
et
al
describ
construct
dna
vaccin
vector
encod
short
bp
long
bp
hairpin
rna
molecul
exert
adjuv
effect
shortstem
molecul
enhanc
apoptosi
report
gene
express
enhanc
induct
antigenspecif
cellular
immun
respons
hand
longstem
rna
increas
apoptosi
enhanc
cellular
immun
question
aris
cell
dsrna
act
enhanc
recruit
innat
immun
result
desir
cellular
immun
anoth
potenti
use
attribut
describ
carvalho
et
al
dna
vaccin
vector
specifi
fusion
target
encod
antigen
extracellular
space
lysosom
andor
endoplasm
reticulum
anoth
issu
often
ignor
deliveri
dna
vaccin
rel
efficaci
induc
protect
immun
abil
dna
vaccin
direct
synthesi
protect
antigen
addit
need
use
bacteri
vector
either
induc
induc
diminish
delay
apoptosispyroptosi
cell
dna
vaccin
deliv
discuss
need
deliv
dna
vaccin
tissu
cell
abl
synthes
protect
antigen
modifi
correctli
posttransl
modif
raska
et
al
demonstr
deliveri
dna
vaccin
encod
hiv
antigen
induc
maxim
humor
immun
respons
dna
vaccin
deliv
iv
manner
enhanc
deliveri
liver
also
note
superior
abil
liver
carri
appropri
glycosyl
antigen
also
contribut
induct
neutral
antibodi
regard
dna
vaccin
deliv
invas
bacteri
strain
salmonella
listeria
effect
colon
liver
spleen
like
better
dna
vaccin
deliveri
noninvas
bacteri
strain
comparison
need
made
studi
relat
amount
antigen
synthes
rel
induct
humor
immun
respons
versu
cellular
immun
tabl
choi
kim
construct
auxotroph
e
tarda
deliv
asd
dna
vaccin
antibioticresist
gene
deliv
gfp
model
antigen
millionfold
attenu
due
lysi
result
absenc
dalanin
vivo
subsequ
work
choi
kim
demonstr
presenc
gfp
activ
liver
spleen
kidney
either
oral
intracoelom
ic
vaccin
oliv
flounder
induc
good
antibodi
titer
e
tarda
gfp
choi
et
al
improv
balancedleth
asd
dna
vaccin
vector
replac
cmv
promot
marin
medaka
oryzia
dancena
promot
found
higher
titer
neutral
antibodi
viral
hemorrhag
septicemia
viru
also
observ
higher
surviv
challeng
flounder
viru
indic
whether
antibodi
mucou
layer
cover
fish
would
indic
induct
mucos
antibodi
sun
et
al
use
rifampicinpassag
rifampicinresist
attenu
e
tarda
strain
sun
et
al
deliv
dna
vaccin
vector
encod
protect
antigen
sun
et
al
fish
pathogen
streptococcu
inia
vaccin
japanes
flounder
paralichthi
olivaceu
oral
bath
immers
induc
partial
immun
challeng
either
virul
e
tarda
inia
huang
et
al
design
highcopi
number
dna
vaccin
vector
use
operatorrepressor
titrat
ort
system
garmori
et
al
maintain
plasmid
stabli
absenc
antibioticresist
marker
select
dna
vaccin
encod
tuberculosi
mpta
antigen
synthesi
vivo
control
cmv
promot
rasv
deliv
dna
vaccin
deliv
intragastr
one
dose
three
dose
prior
aerosol
challeng
tuberculosi
bcg
given
sc
group
mice
posit
control
although
vaccin
decreas
bacteri
load
lung
spleen
bcg
vaccin
much
effect
mucos
immun
respons
mpta
antigen
monitor
mention
made
whether
mpta
glycosyl
vivo
ning
et
al
made
deriv
encod
envelop
protein
white
spot
syndrom
viru
wssv
kill
crayfish
deliv
typhimurium
dam
phop
mutat
typhimurium
fed
food
crayfish
foot
mouth
diseas
viru
fmdv
l
acidophilu
li
et
al
advers
effect
therefor
crayfish
oral
immun
typhimurium
recombin
dna
vaccin
vector
vaccin
strain
persist
tissu
day
induc
signific
protect
immun
crayfish
inject
wssv
dose
kill
control
natur
basi
protect
immun
discuss
suspect
sinc
ort
system
design
loss
lead
dapless
death
possibl
antigen
synthes
salmonella
could
releas
act
immunogen
jiao
et
al
use
pvax
vector
encod
infecti
bronchiti
viru
ibv
n
gene
product
oral
nasal
deliv
chicken
aroa
typhimurium
strain
mucos
system
antibodi
respons
induc
immun
chicken
demonstr
protect
immun
challeng
ibv
result
rout
immun
yang
et
al
specifi
glycosyl
spike
protein
tgev
pvax
deliv
aroa
typhimurium
strain
oral
immun
mice
induc
mucos
humor
antitgev
antibodi
highest
dose
vaccin
given
cfu
gave
highest
antibodi
titer
wan
et
al
construct
pvax
dna
vaccin
vector
encod
two
avian
reoviru
envelop
protein
capabl
induc
neutral
antibodi
introduc
aroa
typhimurium
strain
chicken
oral
immun
three
dose
cfu
interv
serum
igg
intestin
iga
induc
chicken
immun
receiv
dna
vaccin
encod
two
env
protein
best
protect
bird
show
sign
infect
day
challeng
yu
et
al
construct
pvax
dna
vaccin
deriv
encod
core
gene
duck
enter
viru
dev
viru
deliv
oral
immun
duckl
use
aroa
typhimurium
strain
mucos
antibodi
induc
bile
intestin
secret
well
dev
neutral
antibodi
serum
duckl
receiv
highest
dose
cfu
demonstr
greatest
protect
dev
challeng
ld
kong
et
al
use
attenu
typhimurium
strain
regul
delay
vivo
lysi
engin
hyperinvas
escap
endosom
scv
lyse
cytosol
caus
reduc
induct
apoptosispyroptosi
enhanc
transcript
dna
vaccin
deliv
effici
nucleu
inclus
nuclear
target
sequenc
dna
vaccin
vector
also
improv
remov
dna
vaccin
vector
sequenc
suscept
digest
host
nucleas
also
minim
includ
enda
mutat
salmonella
elimin
potent
endonucleas
dna
vaccin
also
strong
transcript
termin
sequenc
either
side
eukaryot
express
cassett
minim
synthesi
influenza
ha
protein
salmonella
prior
lysi
vaccin
induc
protect
mice
challeng
ld
wsn
influenza
viru
vecino
et
al
evalu
flexneri
vaccin
vector
deliv
dna
vaccin
encod
influenza
viru
ha
vaccin
mice
induc
protect
immun
influenza
viru
challeng
although
antiha
iga
detect
bronchoalveolar
lavag
fluid
four
immun
titer
substanti
increas
lethal
influenza
viru
respiratori
challeng
li
et
al
construct
eukaryot
express
vector
express
foot
mouth
diseas
viru
fmdv
protein
encod
l
plantarum
plasmid
replicon
deliveri
l
acidophilu
compar
studi
conduct
use
intragastr
ip
im
immun
highest
titer
antibodi
achiev
im
ip
immun
mucos
rout
immun
effect
rabv
potenti
persist
vivo
either
tissu
intestin
tract
well
known
typhi
paratyphi
persist
adher
gallston
gallbladd
later
shed
fece
genet
attribut
involv
biofilm
format
need
persist
investig
review
see
gonzalezescobedo
et
al
includ
mutat
block
synthesi
thin
aggreg
fimbria
colan
acid
lp
oantigen
vivo
rasv
typhi
strain
deliv
pneumococc
pspa
antigen
mean
block
persist
baumler
colleagu
kingsley
et
al
kingsley
et
al
ween
et
al
investig
role
fimbrial
adhesin
persist
intestin
tract
well
import
typhimurium
surfac
antigen
bind
extracellular
matrix
protein
also
facilit
intestin
persist
mutat
contribut
featur
significantli
attenu
strain
studi
need
sinc
strain
attribut
often
difficult
recov
immun
anim
shed
fece
human
volunt
need
dna
vaccin
deliveri
vector
lyse
vivo
discuss
although
gramposit
vaccin
vector
lactic
acid
bacteria
lp
lipid
endotoxin
case
gramneg
pathogen
gunn
et
al
demonstr
use
rabbit
ileal
loop
inclus
andor
mutat
typhimurium
significantli
reduc
intestin
inflamm
fluid
secret
kong
et
al
genet
modifi
typhimurium
inclus
sever
delet
mutat
insert
codonoptim
lpxe
gene
francisella
tularensi
produc
lipid
nontox
strong
adjuv
activ
mutat
particularli
use
strain
regul
delay
lysi
vivo
kong
et
al
kong
et
al
well
strain
undergo
lysi
mean
discuss
sinc
case
endotoxin
releas
lysi
could
result
cytokin
storm
sepsi
sinc
live
bacteri
vaccin
potenti
surviv
exit
immun
individu
also
invari
genet
modifi
appropri
consid
might
modifi
ensur
nonsurviv
environ
although
success
live
polio
vaccin
contribut
excret
vaccin
viru
contamin
waterway
lead
involuntari
immun
mani
establish
uneth
vaccin
individu
elect
immun
give
inform
consent
also
econom
basi
biolog
contain
nonsurviv
vaccin
strain
environ
relev
vaccin
use
control
infect
agricultur
import
anim
commerci
develop
depend
repeat
sale
vaccin
kong
et
al
kong
et
al
describ
two
regul
delay
lysi
vivo
system
one
deliveri
protect
antigen
synthes
salmonella
vaccin
strain
deliveri
dna
vaccin
express
gene
encod
protect
antigen
within
nucleu
cell
immun
anim
host
former
case
synthes
antigen
deliv
combin
use
antigen
secret
either
well
lysi
juarezrodriguez
et
al
strain
unabl
persist
vivo
fail
surviv
excret
kim
et
al
construct
condit
lethal
typhimurium
strain
use
arac
p
bad
asd
fusion
use
arac
p
bad
typhimurium
asd
strain
genet
construct
analog
strain
mura
tt
arac
p
bad
mura
construct
kong
et
al
case
strain
commenc
lyse
sever
cell
divis
persist
long
achiev
high
titer
effector
lymphoid
tissu
recombin
regul
delay
lysi
strain
construct
kong
et
al
kong
et
al
construct
would
provid
complet
biolog
contain
grangett
et
al
use
alr
mutant
lactobacillu
plantarum
l
lacti
like
shigella
strain
sizemor
et
al
vecino
et
al
commenc
undergo
lysi
vaccin
even
dalanin
dap
suppli
process
type
mutat
confer
complet
biolog
contain
lee
describ
multipl
mean
attenu
provid
biocontain
lactobacillu
strain
note
genet
modifi
microorgan
gmm
longer
gener
recogn
safe
gra
also
stress
gmm
vaccin
express
antibiot
resist
attribut
discuss
alr
mutant
pyrimidinerequir
mutant
note
thya
mutant
bacteriocid
absenc
thymidin
thymin
wherea
pyr
mutant
bacteriostat
absenc
pyrimidin
furthermor
thya
mutant
l
lacti
stabli
maintain
pig
shown
steidler
et
al
recogn
thya
mutat
human
insert
might
replac
thya
gene
bacterium
mainli
concern
survivalpersist
thya
vaccin
strain
excret
thymineless
death
condit
would
suffici
interest
sinc
thya
mutant
typhimurium
attenu
curtiss
kelli
cours
l
lacti
need
addit
attenu
therefor
clear
whether
thya
mutat
would
need
attenu
even
provid
biolog
contain
intestin
tract
contain
substanti
quantiti
digest
dna
compon
guan
et
al
fuse
fur
regul
promot
p
vlub
e
gene
introduc
transmembran
hole
test
efficaci
laboratori
e
coli
strain
anim
hard
know
whether
iron
concentr
would
repress
derepress
e
gene
thu
might
well
coupl
e
gene
fur
tt
arac
p
bad
fur
construct
whether
system
describ
provid
complet
biolog
contain
establish
wang
et
al
delet
gene
twin
arginin
secret
pathway
render
e
tarda
saltsensit
also
sensit
stress
thu
confer
contain
use
marin
environ
howev
delet
suffici
attenu
mean
would
requir
e
tarda
recombin
vaccin
test
done
see
strategi
contribut
biolog
contain
express
genet
inform
heterolog
organ
need
screen
sequenc
recogn
regulatori
protein
would
interfer
gene
express
caus
fals
intern
transcript
initi
also
express
bacteri
sequenc
eukaryot
might
lead
posttransl
modif
glycosyl
would
lead
induct
nonprotect
immun
respons
reciproc
true
viral
fungal
parasit
antigen
synthes
bacteria
kindsmul
wagner
review
use
synthet
biolog
comput
algorithm
mean
advanc
vaccin
design
increas
success
mani
research
start
use
sitedirect
mutagenesi
codon
optim
improv
promot
design
year
ago
mani
us
clone
gene
year
prefer
instead
synthes
revers
vaccinolog
rappuoli
bioinformat
analys
gener
use
year
identifi
surfac
expos
antigen
signal
secret
sequenc
protein
fusion
partner
antigen
export
target
one
perplex
discoveri
last
sever
year
find
cytoplasm
protein
mean
yet
discov
export
bacteri
cell
induc
protect
immun
protect
partial
protect
antigen
identifi
mycobacterium
clostridium
streptococcu
possibl
impli
someth
uniqu
gramposit
bacteri
pathogen
one
possibl
releas
antigen
format
membran
vesicl
pradosrosal
et
al
yang
et
al
thay
et
al
releas
vivo
stimul
immun
respons
cytoplasm
protein
must
import
virul
think
interest
engin
comput
scientist
interest
genet
engin
oblig
renam
disciplin
synthet
biolog
possibl
avoid
need
master
essenti
knowledg
biolog
genet
genet
engin
howev
often
progress
appli
new
approach
reli
bioinformat
comput
scienc
slow
incorpor
new
approach
engin
scienc
problem
cours
mani
us
prefer
cerebr
approach
scienc
requir
bench
work
achiev
understand
rather
embrac
mindless
costli
highthroughput
screen
hope
effortless
discoveri
someth
import
import
facet
design
develop
rabv
antigen
dna
vaccin
deliveri
induc
mucos
antibodi
cellular
immun
respons
sinc
ultim
object
deliv
vaccin
construct
safe
efficaci
protect
anim
human
infecti
diseas
agent
follow
one
contempl
conduct
relev
preclin
studi
valid
vaccin
perform
secur
approv
fund
advanc
effort
commenc
clinic
trial
one
also
consid
mean
manufactur
preserv
lastli
regulatori
issu
associ
use
live
vaccin
genet
modifi
consider
import
restrict
discuss
use
live
bacteri
vector
deliveri
antigen
dna
vaccin
prevent
infecti
diseas
system
also
develop
anticanc
therapi
alter
anim
host
physiolog
develop
contracept
vaccin
applic
direct
control
zoonot
diseas
well
induc
infertil
rodent
popul
vector
consum
harvest
food
